201 related articles for article (PubMed ID: 8968101)
1. Genotoxicity of aflatoxin B1: evidence for a recombination-mediated mechanism in Saccharomyces cerevisiae.
Sengstag C; Weibel B; Fasullo M
Cancer Res; 1996 Dec; 56(23):5457-65. PubMed ID: 8968101
[TBL] [Abstract][Full Text] [Related]
2. DNA recombination induced by aflatoxin B1 activated by cytochrome P450 1A enzymes.
Sengstag C; Würgler FE
Mol Carcinog; 1994 Dec; 11(4):227-35. PubMed ID: 7999264
[TBL] [Abstract][Full Text] [Related]
3. Activation of aflatoxin B1 by expression of human CYP1A2 polymorphisms in Saccharomyces cerevisiae.
Fasullo M; Smith A; Egner P; Cera C
Mutat Res Genet Toxicol Environ Mutagen; 2014 Feb; 761():18-26. PubMed ID: 24472830
[TBL] [Abstract][Full Text] [Related]
4. Heterocyclic aromatic amines efficiently induce mitotic recombination in metabolically competent Saccharomyces cerevisiae strains.
Paladino G; Weibel B; Sengstag C
Carcinogenesis; 1999 Nov; 20(11):2143-52. PubMed ID: 10545418
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of promutagens catalyzed by Drosophila melanogaster CYP6A2 enzyme in Saccharomyces cerevisiae.
Saner C; Weibel B; Wurgler FE; Sengstag C
Environ Mol Mutagen; 1996; 27(1):46-58. PubMed ID: 8625948
[TBL] [Abstract][Full Text] [Related]
6. High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductase.
Sengstag C; Eugster HP; Würgler FE
Carcinogenesis; 1994 May; 15(5):837-43. PubMed ID: 8200084
[TBL] [Abstract][Full Text] [Related]
7. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
[TBL] [Abstract][Full Text] [Related]
8. Rearrangements in minisatellite sequences induced by aflatoxin B1 in a metabolically competent strain of Saccharomyces cerevisiae.
Kaplanski C; Wild CP; Sengstag C
Carcinogenesis; 1998 Sep; 19(9):1673-8. PubMed ID: 9771940
[TBL] [Abstract][Full Text] [Related]
9. Interaction of aflatoxin B1 with cytochrome P450 2A5 and its mutants: correlation with metabolic activation and toxicity.
Pelkonen P; Lang MA; Negishi M; Wild CP; Juvonen RO
Chem Res Toxicol; 1997 Jan; 10(1):85-90. PubMed ID: 9074807
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional response of yeast to aflatoxin B1: recombinational repair involving RAD51 and RAD1.
Keller-Seitz MU; Certa U; Sengstag C; Würgler FE; Sun M; Fasullo M
Mol Biol Cell; 2004 Sep; 15(9):4321-36. PubMed ID: 15215318
[TBL] [Abstract][Full Text] [Related]
11. Expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae reveals a functional role in aflatoxin B1 detoxification.
Kelly EJ; Erickson KE; Sengstag C; Eaton DL
Toxicol Sci; 2002 Jan; 65(1):35-42. PubMed ID: 11752683
[TBL] [Abstract][Full Text] [Related]
12. An in vitro system for measuring genotoxicity mediated by human CYP3A4 in Saccharomyces cerevisiae.
Fasullo M; Freedland J; St John N; Cera C; Egner P; Hartog M; Ding X
Environ Mol Mutagen; 2017 May; 58(4):217-227. PubMed ID: 28436563
[TBL] [Abstract][Full Text] [Related]
13. Expression of a human cytochrome p450 in yeast permits analysis of pathways for response to and repair of aflatoxin-induced DNA damage.
Guo Y; Breeden LL; Zarbl H; Preston BD; Eaton DL
Mol Cell Biol; 2005 Jul; 25(14):5823-33. PubMed ID: 15988000
[TBL] [Abstract][Full Text] [Related]
14. CYP1B1 converts procarcinogens into genotoxins in Saccharomyces cerevisiae.
Kannan A; Perpetua N; Dolan M; Fasullo M
Mutat Res Genet Toxicol Environ Mutagen; 2022; 874-875():503440. PubMed ID: 35151423
[TBL] [Abstract][Full Text] [Related]
15. Human CYP1A1-activated aneugenicity of aflatoxin B1 in mammalian cells and its combined effect with benzo(a)pyrene.
Wang H; Fan Q; Liang Q; Wu Y; Ye Z; Wu H; Sun Q; Tang H; Liu Y; Liu Q; Chen Y
Chem Biol Interact; 2024 Apr; 392():110923. PubMed ID: 38382706
[TBL] [Abstract][Full Text] [Related]
16. Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens.
Kranendonk M; Mesquita P; Laires A; Vermeulen NP; Rueff J
Mutagenesis; 1998 May; 13(3):263-9. PubMed ID: 9643585
[TBL] [Abstract][Full Text] [Related]
17. Retroviral expression of the hepatitis B virus x gene promotes liver cell susceptibility to carcinogen-induced site specific mutagenesis.
Sohn S; Jaitovitch-Groisman I; Benlimame N; Galipeau J; Batist G; Alaoui-Jamali MA
Mutat Res; 2000 Jun; 460(1):17-28. PubMed ID: 10856831
[TBL] [Abstract][Full Text] [Related]
18. Alteration of aflatoxin B1 metabolic profiles and reduction of aflatoxin B1 mutagenicity by hepatic microsomes of rats fed butylated hydroxyanisole.
Choi CY; Park SH; Park EH; Cha YN
J Toxicol Sci; 1991 Feb; 16 Suppl 1():119-32. PubMed ID: 1920539
[TBL] [Abstract][Full Text] [Related]
19. Liver carcinogen aflatoxin B1 as an inducer of mitotic recombination in a human cell line.
Stettler PM; Sengstag C
Mol Carcinog; 2001 Jul; 31(3):125-38. PubMed ID: 11479921
[TBL] [Abstract][Full Text] [Related]
20. Genome Profiling for Aflatoxin B
St John N; Freedland J; Baldino H; Doyle F; Cera C; Begley T; Fasullo M
G3 (Bethesda); 2020 Nov; 10(11):3929-3947. PubMed ID: 32994210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
